Literature DB >> 11806883

Meningococcal bacterial DNA load at presentation correlates with disease severity.

S J Hackett1, M Guiver, J Marsh, J A Sills, A P J Thomson, E B Kaczmarski, C A Hart.   

Abstract

AIMS: To determine bacterial loads in meningococcal disease (MCD), their relation with disease severity, and the factors which determine bacterial load.
METHODS: Meningococcal DNA quantification was performed by the Taqman PCR method on admission and sequential blood samples from patients with MCD. Disease severity was assessed using the Glasgow Septicaemia Prognostic Score (GMSPS, range 0-15, severe disease > or =8).
RESULTS: Median admission bacterial load was 1.6 x 10(6) DNA copies/ml of blood (range 2.2 x 10(4) to 1.6 x 10(8)). Bacterial load was significantly higher in patients with severe (8.4 x 10(6)) compared to milder disease (1.1 x 10(6), p = 0.018). This difference was greater in septicaemic patients (median 1.6 x 10(7) versus 9.2 x 10(5), p < 0.001). Bacterial loads were significantly higher in patients that died (p = 0.017). Admission bacterial load was independent of the duration of clinical symptoms prior to admission, with no difference between the duration of symptoms in mild or severe cases (median, 10.5 and 11 hours respectively). Bacterial loads were independent of DNA elimination rates following treatment.
CONCLUSION: Patients with MCD have higher bacterial loads than previously determined with quantitative culture methods. Admission bacterial load is significantly higher in patients with severe disease (GMSPS > or =8) and maximum load is highest in those who die. Bacterial load is independent of the duration of clinical symptoms or the decline in DNA load.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11806883      PMCID: PMC1719043          DOI: 10.1136/adc.86.1.44

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients.

Authors:  M Guiver; A J Fox; K Mutton; N Mogulkoc; J Egan
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

2.  Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease.

Authors:  M A Sobanski; R A Barnes; S J Gray; A D Carr; E B Kaczmarski; A O'Rourke; K Murphy; M Cafferkey; R W Ellis; K Pidcock; P Hawtin; W T Coakley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-04       Impact factor: 3.267

3.  An interleukin-1 genotype is associated with fatal outcome of meningococcal disease.

Authors:  R C Read; N J Camp; F S di Giovine; R Borrow; E B Kaczmarski; A G Chaudhary; A J Fox; G W Duff
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA.

Authors:  M Guiver; R Borrow; J Marsh; S J Gray; E B Kaczmarski; D Howells; P Boseley; A J Fox
Journal:  FEMS Immunol Med Microbiol       Date:  2000-06

5.  Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.

Authors:  R G Westendorp; J J Hottenga; P E Slagboom
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

6.  Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).

Authors:  H Uronen; A J Williams; G Dixon; S R Andersen; P Van Der Ley; M Van Deuren; R E Callard; N Klein
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

7.  Genetic influence on cytokine production and fatal meningococcal disease.

Authors:  R G Westendorp; J A Langermans; T W Huizinga; A H Elouali; C L Verweij; D I Boomsma; J P Vandenbroucke; J P Vandenbrouke
Journal:  Lancet       Date:  1997-01-18       Impact factor: 79.321

8.  Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey.

Authors:  A P Thomson; J A Sills; C A Hart
Journal:  Crit Care Med       Date:  1991-01       Impact factor: 7.598

9.  Relationship between the magnitude of bacteremia in children and the clinical disease.

Authors:  T D Sullivan; L J LaScolea; E Neter
Journal:  Pediatrics       Date:  1982-06       Impact factor: 7.124

10.  Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.

Authors:  M van Deuren; J van der Ven-Jongekrijg; A K Bartelink; R van Dalen; R W Sauerwein; J W van der Meer
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  56 in total

Review 1.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid.

Authors:  Richard Rothman; Padmini Ramachandran; Samuel Yang; Andrew Hardick; Helen Won; Aleksandar Kecojevic; Celeste Quianzon; Yu-Hsiang Hsieh; Charlotte Gaydos
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

Review 3.  Meningococcal disease and its management in children.

Authors:  C Anthony Hart; Alistair P J Thomson
Journal:  BMJ       Date:  2006-09-30

4.  High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Ya-Chi Ho; Shan-Chwen Chang; Su-Ru Lin; Wei-Kung Wang
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  The potential for PCR based testing to improve diagnosis and treatment of sepsis.

Authors:  Ngan Lyle; John Boyd
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 6.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

7.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

8.  Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Authors:  Reidun Øvstebø; Petter Brandtzaeg; Berit Brusletto; Kari Bente Foss Haug; Knut Lande; Ernst Arne Høiby; Peter Kierulf
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children.

Authors:  Penelope A Bryant; Hua Yi Li; Angelo Zaia; Julia Griffith; Geoff Hogg; Nigel Curtis; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.